Small cell lung cancer (staging - superseded)

Last revised by Craig Hacking ◉ ◈ on 4 Jun 2020

Citation, DOI, disclosures and article data

Citation:

Gaillard F, Hacking C, Bell D, et al. Small cell lung cancer (staging - superseded). Reference article, Radiopaedia.org (Accessed on 21 Sep 2023) https://doi.org/10.53347/rID-8591

DOI:

https://doi.org/10.53347/rID-8591

Permalink:

https://radiopaedia.org/articles/8591

rID:

8591

Article created:

15 Feb 2010, Frank Gaillard ◉ ◈

Disclosures:

At the time the article was created Frank Gaillard had no recorded disclosures.

View Frank Gaillard's current disclosures

Last revised:

4 Jun 2020, Craig Hacking ◉ ◈

Disclosures:

At the time the article was last revised Craig Hacking had no recorded disclosures.

View Craig Hacking's current disclosures

Revisions:

22 times, by 10 contributors - see full revision history and disclosures

Systems:

Chest, Oncology

Sections:

Staging

Tags:

refs

Previously, small cell lung cancer (SCLC) was not staged in the same manner as non-small cell lung cancer (NSCLC), but since 2013 both are staged using the IASLC (International Association for the Study of Lung Cancer) lung cancer staging system (currently in its 8th edition, published in 2016).

The idea behind a different staging system for SCLC was on account of it being almost never resectable at the time of diagnosis, except in rare cases where it appears as a solitary pulmonary nodule. The staging was performed dividing the tumors as such:

limited
- disease confined to one hemithorax
- inclusive of hilar/supraclavicular lymph nodes
- patients were suitable for radiation therapy as well as chemotherapy
extensive
- disease extends beyond one hemithorax
- patients received only chemotherapy
- accounted for 70% of cases